Pro Medicus (OTCMKTS:PMCUF) Shares Down 3.9% – Time to Sell?

Pro Medicus Limited (OTCMKTS:PMCUF) shares dropped 3.9% during trading on Friday . The company traded as low as $109.47 and last traded at $109.47. Approximately 7,297 shares traded hands during trading, an increase of 853% from the average daily volume of 766 shares. The stock had previously closed at $113.9150.

Analysts Set New Price Targets

Separately, Jefferies Financial Group set a $155.00 target price on Pro Medicus and gave the company a “buy” rating in a research note on Thursday, February 12th. One investment analyst has rated the stock with a Buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $155.00.

Pro Medicus Stock Down 3.9%

The stock’s 50 day simple moving average is $97.17 and its two-hundred day simple moving average is $112.14.

Pro Medicus Company Profile

Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.

The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.